首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1666195

全球气相层析系统市场 - 2025 - 2032

Global Gas Chromatography Systems Market - 2025-2032

出版日期: 2025年02月24日 | 出版商:

DataM Intelligence | 英文 205 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球气相层析系统市场规模达到 36.6875 亿美元，预计到 2032 年将达到 72.0359 亿美元，在 2025-2032 年预测期内的复合年增长率为 8.8%。

推动这一成长的因素包括色谱技术的进步、各行业应用的增加以及政府对环境监测和食品安全的严格监管。气相层析法 (GC) 在製药业应用的最重要领域之一是药物开发和品质控製程序。根据印度品牌资产基金会（IBEF）的数据，印度製药业预计将发生转型，到 2024 年规模约为 650 亿美元，到 2030 年增至 1,300 亿美元，然后到 2047 年迅速增至 4,500 亿美元。

目前，印度製药业价值估计为500亿美元，光是出口就贡献了250多亿美元。这凸显了在药品製造过程中采用气相层析法等先进技术的必要性，以遵守各种与健康相关的法规，因为它提供了扩展的空间。事实上，这些地区的环境和食品安全问题已经严重影响了北美和欧洲市场以及医疗和製药领域开发和实施气相层析法的努力。

此外，这些政府已经认识到采用这些方法解决食品安全和环境污染问题的必要性。例如，综合加拿大的研究资助机构加拿大创新基金会 (CFI) 已投资约 900 万美元用于开发必要的基础设施，其中包括促进气相层析质谱 (GC-MS) 研究。

动力学

医疗保健和製药领域的重要应用

持续的技术进步和产业内策略合作的形成。 GC 系统的多样化应用也是其成长的因素。这些应用涵盖法医科学、环境测试、製药、化学品和食品安全。多样化的可用性确保了现有和发展中经济体市场需求的持续涌入。气相层析市场具有良好的未来成长潜力，因为其特点是永续性和法规遵循性，以及新产品的推出。

预计预测期内医药最终用途的气相层析系统将经历大幅成长。 2023 年该领域的价值估计为 9.8247 亿美元，预计 2024 年至 2031 年的年复合成长率(CAGR) 为 11.0%。该市场扩张的主要原因是在监管药品註册、品质控制和药物开发过程中实施有效分析方法的必要性日益增长。

区域和全球合作不断增多

世界各国政府已经认识到色谱技术在解决医疗保健、环境永续性和食品安全方面的挑战的价值。加拿大政府投资了商业创新计划，支持 Natrix Separations 等公司开发用于生物製药製造的先进一次性色谱产品。

这些投资促进了尖端气相层析技术的商业化，促进了精密仪器的发展和普及。同样，欧盟透过「地平线欧洲」等项目积极资助合作研究项目，重点在于改进包括气相层析系统在内的分析仪器，以满足严格的环境和食品安全法规。

此外，公私合作伙伴关係在推进 GC 技术方面发挥关键作用。这种合作充分利用了私人公司和公共机构的资源和专业知识。例如，公私合作伙伴关係在推进 GC 技术方面发挥关键作用。这种合作充分利用了私人公司和公共机构的资源和专业知识。例如，美国环保署 (EPA) 与 GC 製造商密切合作，以增强用于空气和水质监测的仪器。这种合作关係确保了法规合规性，同时促进了仪器设计的创新。

高度依赖专用载气

气相层析（GC）系统市场主要依赖专门的载气，例如氦气。由于氦气具有质量分离能力和非反应性，因此在气相层析操作中是必不可少的。然而，全球范围内的氦「危机」导致其价格变得更加昂贵且取得更加困难。生物系统的利用受到氦气成本和供应量的上升的影响。美国能源部 (DOE) 报告称，GC 价格昂贵，无法用于医疗和研究应用。

此外，由于全球氦气稀缺，因此必须使用氢气或氮气等被视为劣质的载气。根据美国国家标准与技术研究所 (NIST) 的数据，氢气成本较低；但它也更易燃，这会带来风险。这些复杂情况增加了实验室和产业的营运和维护成本，需要实施额外的安全措施和设施。

The growth is driven by advancements in chromatography technologies, increased applications across industries and strong governmental regulations for environmental monitoring and food safety. One of the most significant sectors for the application of gas chromatography (GC) in the pharmaceutical industry is drug development and quality control procedures. The pharmaceutical sector in India is expected to transform, with a size of approximately US$ 65 billion by 2024, increasing to US$ 130 billion by 2030 and then rapidly increasing to US$ 450 billion by 2047, according to the India Brand Equity Foundation (IBEF).

Currently, it is estimated that the Indian pharmaceutical industry is worth US$ 50 billion, with a contribution of over US$ 25 billion from exports alone. This underscores the necessity of employing sophisticated techniques, such as gas chromatography, to comply with a variety of health-related regulations during the drug manufacturing process, as it provides space for expansion. In reality, the environmental and food safety concerns in these regions have significantly impacted efforts to develop and implement gas chromatography in North America and European markets, in addition to the medical and pharmaceutical sectors.

Additionally, these governments have acknowledged the necessity of employing these methods to resolve concerns regarding food safety and environmental pollution. For example, the Canada Foundation for Innovation (CFI), the research funding body of Integrated Canada, has invested approximately $9 million in the development of the requisite infrastructure, which includes facilitating gas chromatography-mass spectrometry (GC-MS) research.

Dynamics

Significant Applications in Healthcare and Pharmaceutical Sector

Ongoing technological advancements and the formation of strategic collaborations within the industry. The diverse applications of GC systems are also a contributing factor to their growth. These applications encompass forensic sciences, environmental testing, pharmaceuticals, chemicals and food safety. The continuous influx of demand for the existing and developing economies markets is ensured by the diverse usability. The gas chromatography market is well-positioned for future growth, as it is characterized by sustainability and regulatory compliance, in addition to the introduction of new products.

It is anticipated that the gas chromatography system in pharmaceutical end-use will experience substantial growth during the forecast period. This segment was estimated to be worth US$ 982.47 Million in 2023 and is anticipated to experience a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031. The primary reason for the expansion of this market is the growing necessity for the implementation of effective analytical methods in the processes of regulatory drug registration, quality control and drug development.

Rising Regional and Global Collaborations

Governments worldwide have recognized the value of chromatography technologies in addressing challenges in healthcare, environmental sustainability and food safety. The Canadian government has invested in the Business Innovation Initiative, which supports companies like Natrix Separations in developing advanced single-use chromatography products for biopharmaceutical manufacturing.

The investments promote the commercialization of cutting-edge GC technologies, facilitating the development of precision instruments and increasing adoption. Similarly, The European Union actively funds collaborative research projects through programs like Horizon Europe, focusing on improving analytical instruments, including GC systems, to meet stringent environmental and food safety regulations.

Furthermore, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, Public-private partnerships play a critical role in advancing GC technology. Such collaborations leverage the resources and expertise of private companies and public institutions. For instance, The Environmental Protection Agency (EPA) works closely with GC manufacturers to enhance instruments used in air and water quality monitoring. This partnership ensures regulatory compliance while fostering innovation in instrument design.

High Dependency on Specialized Carrier Gases

The market for gas chromatography (GC) systems is primarily dependent on specialized carrier gases, such as helium. Helium is essentially indispensable in the operation of GCs due to its capacity for quality separation and non-reactivity. However, there is a global helium "crisis" that renders it significantly more expensive and difficult to obtain. The utilization of a biosystem was influenced by the rise in the cost and supply of helium. The US Department of Energy (DOE) has reported that GC has been rendered expensive and inaccessible for use in both medical and research applications.

Additionally, the global scarcity of helium necessitates the use of carrier gases, such as hydrogen or nitrogen, which are regarded as inferior. According to the National Institute of Standards and Technology (NIST), hydrogen is less expensive; however, it is also more flammable, which poses a risk. These complications increase the costs of operations and maintenance for laboratories and industries, necessitating the implementation of additional safety measures and facilities.

Segment Analysis

The global gas chromatography systems market is segmented based on product type, sample type, end-user and region.

Adoption of Advanced Detectors Fuels the Demand of Gas Chromatography Systems Instruments

The instruments segment is poised for steady growth, driven by technological advancements, regulatory requirements and increasing demand across sectors including pharmaceuticals, food safety and environmental monitoring. Key factors include the adoption of advanced detectors, integration with automation software and the miniaturization of portable units.

For instance, in May 2024, Agilent Technologies launched the 8850 Gas Chromatograph (GC) System, a compact single-channel GC that blends the legacy of the 6850 GC with the advanced capabilities of the 8890 GC. Designed for efficiency and intelligence, the 8850 GC is tailored to meet the needs of modern labs in energy, chemicals, food and pharmaceuticals, offering up to 30% reduced energy consumption. It addresses key challenges such as maximizing productivity within limited bench space and aligning operations with sustainability goals by enhancing instrument uptime and operational efficiency.

Geographical Penetration

Rising Demand for Accurate Chemical Analysis in North America

North America gas chromatography market is witnessing consistent expansion, primarily fueled by innovations in analytical methodologies and a rising demand for accurate chemical analysis across various sectors. Critical areas including medicines, environmental monitoring, food and drinks and chemicals are driving the increasing demand for gas chromatography equipment. Technological developments, including miniaturization, automation and the integration of artificial intelligence (AI) for data processing, are boosting the capabilities and efficiency of gas chromatography systems, further expanding their market presence.

Gas chromatography has found significant application in the oil and gas industry, where it plays a key role in assuring the quality and uniformity of chemical analysis. In recent years, North America's total crude oil output attained 46,233,753 Terajoules (TJ), reflecting a 66% increase from 2000, as reported by the International Energy Agency (IEA). The rise of the oil and gas sector is directly fostering the growth of the gas chromatography market, as these systems are essential for analyzing the composition of hydrocarbons and other gases.

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Bruker Corporation, PerkinElmer, Inc., Merck KGAA, Shimadzu Corporation, Waters Corporation, Emerson Electric Co., SCION Instruments and Danaher Corporation.

Sustainable Analysis

Gas chromatography plays a crucial role in environmental sustainability by ensuring the precise identification and quantification of contaminants. Its accuracy and versatility render it essential for assessing ecological well-being and adhering to changing requirements These cutting-edge instruments address evolving industry needs across pharmaceuticals, food safety and environmental monitoring. With a focus on productivity and sustainability, the market is poised for sustained growth across diverse applications.

The demand for gas chromatography is especially prominent in areas prioritizing healthcare improvements. The National Cancer Center of Japan estimated more than 1 million new cancer cases in 2022, highlighting the increasing demand for accurate analytical methods in oncology research. In Saudi Arabia, the Vision 2030 project has catalyzed investments in healthcare, biotechnology and environmental sustainability.

Recent Developments

In October 2024, Bruker BioSpin Group has announced the acquisition of Bridge12's Electron Paramagnetic Resonance (EPR) business. This acquisition enhances Bruker's suite of EPR spectroscopy offerings, including Bridge12's modular EPR bridges for pulsed spectroscopy, high-field EPR spectrometers for multi-frequency experiments, microwave amplifiers and EPR probes. The addition of Bridge12's innovative technology, including its compact Q-Band EPR resonator for small sample analysis, strengthens Bruker's position in the research industry.
In June 2024, Agilent Technologies Inc. has introduced the Agilent 7010D Triple Quadrupole GC/MS System (7010D GC/TQ). To target the food and environmental markets, the 7010D GC/TQ features the new HES 2.0 ion source, offering attogram-level sensitivity, advanced built-in intelligence and environmentally conscious design with the My Green Lab ACT Label. Paired with the MassHunter Acquisition 13.0 software, the system enhances data integrity and compliance, reflecting Agilent's commitment to precision and sustainability.
In December 2023, PerkinElmer Inc. has announced its acquisition of Covaris, to create an innovation-driven global life sciences and diagnostics platform. This strategic move will accelerate Covaris' growth potential and broaden PerkinElmer's portfolio, particularly in the rapidly expanding diagnostics market. The merger strengthens PerkinElmer's position in genomics, transcriptomics and proteomics, offering significant growth opportunities in diagnostics, biopharma and clinical research globally.

By Product Type

Instrument
- Gas Chromatography-Mass Spectrometry (GC-MS)
- Gas Chromatography-Flame Ionization Detection (GC-FID)
- Gas Chromatography-Electron Capture Detection (GC-ECD)
- Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
- Others
Accessories & Reagents

By Sample Type

Gas-Liquid Chromatography (GLC)
Gas-Solid Chromatography (GSC)

By End-User

Pharmaceutical Companies
Biotechnology Companies
Forensic Departments
Academic and Research Institutes
F&B Industries
Oil & Gas Industries
Environmental Testing Agencies
Others

By Region

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Why Purchase the Report?

To visualize the global gas chromatography systems market segmentation based on product type, sample type, end-user, & region.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points at the gas chromatography systems market level for all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global gas chromatography systems market report would provide approximately 62 tables, 55 figures and 205 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Sample Type
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Significant Applications in Healthcare and Pharmaceutical Sector
  - 4.1.1.2. Rising Regional and Global Collaborations
- 4.1.2. Restraints
  - 4.1.2.1. High Dependency on Specialized Carrier Gases
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainable Analysis
5.6. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Instruments*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 6.2.2.1. Gas Chromatography-Mass Spectrometry (GC-MS)
  - 6.2.2.2. Gas Chromatography-Flame Ionization Detection (GC-FID)
  - 6.2.2.3. Gas Chromatography-Electron Capture Detection (GC-ECD)
  - 6.2.2.4. Gas Chromatography-Nitrogen-phosphorus detector (GC-NPD)
  - 6.2.2.5. Others
6.3. Accessories & Reagents

7. By Sample Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 7.1.2. Market Attractiveness Index, By Sample Type
7.2. Gas-Liquid Chromatography (GLC)*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gas-Solid Chromatography (GSC)

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Pharmaceutical Companies*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Biotechnology Companies
8.4. Forensic Departments
8.5. Academic and Research Institutes
8.6. F&B Industries
8.7. Oil & Gas Industries
8.8. Environmental Testing Agencies
8.9. Others

9. Sustainability Analysis

9.1. Environmental Analysis
9.2. Economic Analysis
9.3. Governance Analysis

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. US
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Key Region-Specific Dynamics
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sample Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Agilent Technologies Inc.
12.3. Bruker Corporation
12.4. PerkinElmer, Inc.
12.5. Merck KGAA
12.6. Shimadzu Corporation
12.7. Waters Corporation
12.8. Emerson Electric Co.
12.9. SCION Instruments
12.10. Danaher Corporation

LIST NOT EXHAUSTIVE